Mechanistic insight into ALK receptor tyrosine kinase in human cancer biology

被引：485
|
作者：
Hallberg, Bengt [1 ]
Palmer, Ruth H. [1 ]
机构：
[1] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden
来源：
NATURE REVIEWS CANCER | 2013年 / 13卷 / 10期
基金：
瑞典研究理事会;
关键词：
ANAPLASTIC LYMPHOMA KINASE; LARGE-CELL LYMPHOMA; INFLAMMATORY MYOFIBROBLASTIC TUMOR; NPM-ALK; LUNG-CANCER; MOLECULAR CHARACTERIZATION; DOWN-REGULATION; TRUNCATED FORM; GROWTH-FACTOR; FUSION GENE;
D O I：
10.1038/nrc3580
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The burgeoning field of anaplastic lymphoma kinase (ALK) in cancer encompasses many cancer types, from very rare cancers to the more prevalent non-small-cell lung cancer (NSCLC). The common activation of ALK has led to the use of the ALK tyrosine kinase inhibitor (TKI) crizotinib in a range of patient populations and to the rapid development of second-generation drugs targeting ALK. In this Review, we discuss our current understanding of ALK function in human cancer and the implications for tumour treatment.
引用
收藏
页码：685 / 700
页数：16
相关论文
共 50 条
  • [31] Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome
    Zhang, Hongbing
    Pao, Lily I.
    Zhou, Aileen
    Brace, Arthur D.
    Halenbeck, Robert
    Hsu, Amy W.
    Bray, Thomas L.
    Hestir, Kevin
    Bosch, Elizabeth
    Lee, Ernestine
    Wang, Gang
    Liu, Haixia
    Wong, Brian R.
    Kavanaugh, W. Michael
    Williams, Lewis T.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (44) : 15741 - 15745
  • [32] Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor
    Zeng, Xianke
    Zhang, Hua
    Oh, Annabell
    Zhang, Yan
    Yee, Douglas
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (01) : 117 - 126
  • [33] Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment
    Yadav, Vivek
    Reang, Jurnal
    Vinita
    Sharma, Prabodh Chander
    Sharma, Kalicharan
    Kumar, Deepak
    Tonk, Rajiv Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS, 2024, 10
  • [34] Mechanistic Insight of Cyclin-Dependent Kinase 5 in Modulating Lung Cancer Growth
    Prince, G. M. Shazzad Hossain
    Yang, Tsung-Ying
    Lin, Ho
    Chen, Mei-Chih
    CHINESE JOURNAL OF PHYSIOLOGY, 2019, 62 (06): : 231 - 240
  • [35] Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
    Mackiewicz, Mark
    Huppi, Konrad
    Pitt, Jason J.
    Dorsey, Tiffany H.
    Ambs, Stefan
    Caplen, Natasha J.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (02) : 663 - 679
  • [36] The Truncated Isoform of the Receptor Tyrosine Kinase ALK Generated by Alternative Transcription Initiation (ALKATI) Induces Chromatin Structural Changes in the Nucleus in a Kinase Activity-Dependent Manner
    Takakura, Yuki
    Yamaguchi, Noritaka
    Honda, Takuya
    Morii, Mariko
    Yuki, Ryuzaburo
    Nakayama, Yuji
    Yamaguchi, Naoto
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (11) : 1968 - 1975
  • [37] Potential Therapeutic Strategy for EGFR-Mutant Lung Cancer With Concomitant EML4-ALK Rearrangement-Combination of EGFR Tyrosine Kinase Inhibitors and ALK Inhibitors
    Huang, Ming-Hung
    Lee, Jih-Hsiang
    Hung, Pei-Shan
    Yang, James Chih-Hsin
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (11):
  • [38] Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion
    Wimmel, A
    Glitz, D
    Kraus, A
    Roeder, J
    Schuermann, M
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (17) : 2264 - 2274
  • [39] Functional Analysis of Somatic Mutations Affecting Receptor Tyrosine Kinase Family in Metastatic Colorectal Cancer
    Duplaquet, Leslie
    Figeac, Martin
    Lepretre, Frederic
    Frandemiche, Charline
    Villenet, Celine
    Sebda, Sheherazade
    Sarafan-Vasseur, Nasrin
    Benozene, Melanie
    Vinchent, Audrey
    Goormachtigh, Gautier
    Wicquart, Laurence
    Rousseau, Nathalie
    Beaussire, Ludivine
    Truant, Stephanie
    Michel, Pierre
    Sabourin, Jean-Christophe
    Galateau-Salle, Francoise
    Copin, Marie-Christine
    Zalcman, Gerard
    De Launoit, Yvan
    Fafeur, Veronique
    Tulasne, David
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (06) : 1137 - 1148
  • [40] The Tyrosine 343 Residue of Nucleophosmin (NPM)-Anaplastic Lymphoma Kinase (ALK) Is Important for Its Interaction with SHP1, a Cytoplasmic Tyrosine Phosphatase with Tumor Suppressor Functions
    Hegazy, Samar A.
    Wang, Peng
    Anand, Mona
    Ingham, Robert J.
    Gelebart, Pascal
    Lai, Raymond
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (26) : 19813 - 19820
12345